Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Pain | |||||
Systematic review |
137 women Data from 1 RCT |
Pain (as measured by mean change in 100 mm visual analogue scale [VAS] pain score)
after 1 menstrual cycle
10.09 with high-velocity, low-amplitude (HVLA) manipulation 8.01 with placebo manipulation |
WMD +2.08 95% CI –3.20 to +7.36 |
Not significant | |
Systematic review |
44 women Data from 1 RCT |
Pain intensity, as measured by a 10 cm VAS pain score
after 1 treatment and 1 menstrual cycle
3.78 with HVLA manipulation 5.19 with placebo manipulation |
WMD –1.41 95% CI –2.55 to –0.27 |
Effect size not calculated | HVLA manipulation |
Systematic review |
26 women Data from 1 RCT |
Pain intensity, assessed on a 10 cm VAS scale
at 3 months
5.6 with Toftness manipulation for 3 months 3.4 with placebo manipulation for 3 months |
WMD 2.20 95% CI 1.38 to 3.02 |
Effect size not calculated | placebo manipulation |
Systematic review |
26 women Data from 1 RCT |
Pain intensity, assessed on a 10 cm VAS scale
at 6 months
1.7 with Toftness manipulation for 3 months 3.1 with placebo manipulation for 3 months |
WMD –1.40 95% CI –2.21 to –0.59 |
Effect size not calculated | Toftness manipulation |